Curcumin exerts its effect via downregulation of the NF-κB, MAPK, and Akt pathways and, in combination with paclitaxel, induces a synergistic reduction in tumor incidence as well as tumor volume in a xenograft model using NOD-SCID mice. Here, NFKB1 is linked to neoplasm.